Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate
Unique ID
C520647
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C520647
Entry Term(s)
AZD 1152
AZD-1152
AZD1152
barasertib
Registry Numbers
0
Heading Mapped to
*Organophosphates
*Quinazolines
Frequency
90
Note
an aurora B kinase inhibitor; structure in first source
Source
J Med Chem 2007 May 3;50(9):2213-24
Indexing Information
Protein Kinase Inhibitors
Date of Entry
2007/06/24
Revision Date
2013/10/24
2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate Preferred
AZD 1152 Narrower
barasertib Narrower
page delivered in 0.005s